With its AI Triage tools already guiding patients through over 27 million health checkups, global health tech company Infermedica has secured $30.0M in Series B funding. Established in 2012, the firm helps users understand their symptoms and navigate complex healthcare systems to find appropriate care.
Infermedica's certified medical devices are used by more than 100 organizations across 35 countries and 26 languages. The company emphasizes medical accuracy, with its tools developed and maintained by a team of over 40 doctors who have contributed more than 155,000 physician work hours. Its modules are MDR Class IIb certified in the EU and compliant with HIPAA and GDPR standards.
.png&w=3840&q=75)
